# Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients

> **NCT01253109** · — · TERMINATED · sponsor: **Sensimed AG** · enrollment: 15 (estimated)

## Conditions studied

- Pigmentary Dispersion Syndrome
- Pigmentary Glaucoma Patients

## Interventions

- **DEVICE:** SENSIMED Triggerfish

## Key facts

- **NCT ID:** NCT01253109
- **Lead sponsor:** Sensimed AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** Law agreement between Triggerfish signal and GAT IOP during both sessions. However, an increase in the Triggerfish signal was observed during jogging phase.
- **Last updated:** 2012-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01253109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01253109, "Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01253109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*